Commentary: The small-molecule 'penalty' is a threat to Mass. biotech sector
In Massachusetts, the convergence of brilliant minds and entrepreneurial spirit has given rise to transformative breakthroughs that are shaping the future of medicine: mRNA vaccines, targeted cancer therapies, gene-editing technology, and more. These advances are not an accident, but rather a product of an ecosystem of academic research institutions, venture funds, small biotech companies and large manufacturers.
This ecosystem is now adapting to new realities set in place by last year's Inflation…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Kendalle Burlin O'Connell, John Stanford Source Type: news
More News: Academia | Accidents | Biotechnology | Cancer | Cancer & Oncology | Cancer Therapy | Cancer Vaccines | Genetics | Health Management | Pharmaceuticals | Vaccines